An international study finds that AI surpasses average radiologists in detecting pancreatic cancer on CT scans using a newly developed benchmark and dataset.
Key Details
- 1The study was led by Radboudumc and published in The Lancet Oncology.
- 2A confidential dataset of nearly 400 patient CT scans was assessed by international experts and used to benchmark over 250 submitted AI models.
- 3The best AI model made correct assessments in 92% of scans, compared to 88% for radiologists, and produced 38% fewer false positives.
- 4The AI outperformed the average radiologist but requires further validation before clinical adoption.
- 5The research was funded by the Hanarth Fund and the EU’s Horizon Europe program.
Why It Matters
This study provides strong evidence for the potential of AI to support radiologists in diagnosing pancreatic cancer, a particularly deadly and hard-to-detect disease. The validated benchmark and international collaboration pave the way for further clinical development and adoption of AI in abdominal CT interpretation.
Source
EurekAlert
Related News
•EurekAlert
NIH-Backed AI Model Predicts Cancer Survival Using Single-Cell Data
Researchers have developed scSurvival, a machine learning tool that uses single-cell tumor data to accurately predict cancer patient survival and identify high-risk cell populations.
•EurekAlert
Deep Learning Pathomics Platform Improves Immunotherapy Prediction in Lung Cancer
A deep learning pathomics platform accurately predicts immunotherapy response in metastatic NSCLC using routine pathology slides.
•EurekAlert
AI Pathology Model Outperforms PD-L1 in Predicting NSCLC Immunotherapy Response
MD Anderson's Path-IO machine learning platform accurately predicts immunotherapy responses in metastatic non-small cell lung cancer, surpassing current biomarker standards.